CMP as on 03-Oct-22 15:59₹ 363.40
Turnover (lac)₹ 1,381
Prev. Close₹ 350.60
Day's Vol (shares)₹ 3,79,924
Day's Range (₹)
CMP as on03-Oct-22 15:56₹ 362.80
Turnover (lac)₹ 83
Prev. Close₹ 349.60
Day's Vol (shares)₹ 51,929
The Ludhiana-based company, which is vertically integrated and produces the essential starting ingredient isobutyl benzene needed to ma
Company achieved an EBITDA Margin of 10.70% in Q1FY23 as compared to 8.6% in Q4FY22.
Rating on Long-term facilities worth Rs140 crore has been reaffirmed at CARE A+, with a Stable outlook.
The Company is manufacturing Paracetamol in its existing Unit No 4, which has been converted as multiproduct facility.
The rating on long-term bank facilities was upgraded from CARE A with a Stable outlook to CARE A+; Stable rating.
The company posted a net profits in the Mar-21 quarter was down 16.63% at Rs75.25cr on the back of halving of EBITDA contribution of th
The company's activities and products were categorized under the essential activities and therefore maintained operations during the lo
The company has made the pre-payment of the term loan of Rs107.70cr till date to reduce its term debt.
Rating agency CARE revised the rating on IOL's long-term bank facilities to CARE BBB+ from CARE BBB- and of short-term bank facilities
Sun Pharmaceuticals, Aurobindo, PEL, Dr. Reddys, Biocon, and Lupin contributed majorly to the gain in the index.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity